eTheRNA Press Release
2020-06-16

eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through toclinical proof of concept

eTheRNA raises EUR 34 million…
read more
Fund+ Press Release
2020-06-16

Fund+ Announces Investment in Ona Therapeutics EUR30 Million Series A financing

Fund+ Announces Investment in Ona…
read more
Immunic Press Release
2020-06-15

Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

Immunic, Inc. Announces First Patients…
read more
Fund+ Press Release
2020-06-15

Notable Board Changes

Notable Board Changes Fund+ Appoints…
read more
Confo Therapeutics Press Release
2020-06-12

Confo Therapeutics Expands Board with Appointment of Rob Scott as Independent Director

Confo Therapeutics Expands Board with…
read more
Immunic Press Release
2020-06-12

Immunic, Inc. Announces Pricing of $25 Million Public Offering of Common Stock

Immunic, Inc. Announces Pricing of…
read more
Novadip Press Release
2020-06-05

Novadip Biosciences to unveil its 3M3 Platform at BIO Digital 2020

Novadip Biosciences to unveil its…
read more
Confo Therapeutics Press Release
2020-06-03

Confo Therapeutics Appoints Paolo Vicini as Chief Development Officer

Confo Therapeutics Appoints Paolo Vicini…
read more
Horama Press Release
2020-05-18

HORAMA appoints life sciences veteran Benedikt Timmerman as new Chairman

HORAMA appoints life sciences veteran…
read more
Immunic Press Release
2020-05-14

Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a Phase 2 Clinical Trial of its Selective Oral DHODH Inhibitor, IMU-838, in COVID-19 Patients

Immunic, Inc. Receives First Regulatory…
read more